Abstract
Previous reports have shown that long-term blockade of corticosterone secretion, by either adrenalectomy or repeated treatment with an inhibitor of corticosterone synthesis, metyrapone, profoundly reduces sensitivity to drugs of abuse. In this report we investigated whether acute blockade of corticosterone secretion has similar effects. Animals received a single injection of metyrapone (50 mg/kg SC) and were tested for their locomotor response to cocaine (15 mg/kg IP) 3 hours later. Acute metyrapone treatment reduced the locomotor response to cocaine by about 50%, and this effect was reversed by corticosterone (20 mg/kg SC). The behavioral effects of these treatments paralleled changes in plasma corticosterone levels 20 minutes after an injection of cocaine. Despite the differences in behavior and corticosterone levels, the brain levels of cocaine in these groups did not differ. These results indicate that the behavioral effects of cocaine can be modified by an acute pharmacological manipulation of corticosterone secretion.
Similar content being viewed by others
Article PDF
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Marinelli, M., Rougé-Pont, F., De Jesus-Oliveira, C. et al. Acute Blockade of Corticosterone Secretion Decreases the Psychomotor Stimulant Effects of Cocaine. Neuropsychopharmacol 16, 156–161 (1997). https://doi.org/10.1016/S0893-133X(96)00169-8
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1016/S0893-133X(96)00169-8
Keywords
This article is cited by
-
Increased cocaine reward in offspring of females exposed to morphine during adolescence
Psychopharmacology (2019)
-
Dissociation of corticotropin-releasing factor receptor subtype involvement in sensitivity to locomotor effects of methamphetamine and cocaine
Psychopharmacology (2012)
-
Potential programming of dopaminergic circuits by early life stress
Psychopharmacology (2011)
-
Individual Differences in Cocaine-induced Locomotor Activity in Rats: Behavioral Characteristics, Cocaine Pharmacokinetics, and the Dopamine Transporter
Neuropsychopharmacology (2003)